SOHO State of the Art Updates and Next Questions | Peripheral T-Cell Lymphoma: Current Landscape and Emerging Questions
Clinical Lymphoma Myeloma and Leukemia · 2026-06 · 26 (6) · 341-350
DOI: 10.1016/j.clml.2026.02.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-06. Verfasst von Seda S Tolu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Columbia University Irving Medical Center, New York, NY. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Peripheral. Die Arbeit nennt 124 Literaturangaben.
Abstract (Originalsprache)
Peripheral T-cell lymphomas (PTCLs) comprise a rare, heterogeneous group of mature T-cell and NK-cell neoplasms, representing approximately 10% to 15% of all non-Hodgkin lymphomas. Despite advances in disease classification and biology, clinical outcomes remain poor for most subtypes other than anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL). This review synthesizes current understanding of nodal PTCL biology-including T-cell follicular helper (TFH)-derived lymphomas, PTCL-NOS, and systemic ALCL. The integration of molecular profiling has deepened our understanding of disease heterogeneity, identifying recurrent epigenetic and signaling pathway alterations that now inform rational, targeted strategies. Brentuximab vedotin-based regimens have reshaped frontline therapy for CD30-positive disease, while ongoing studies are exploring the role of novel therapies including epigenetic modulators, phosphatidylinositol 3-kinase (PI3K) and JAK inhibitors, and immune-based therapies across the PTCL spectrum. Future progress will depend on biomarker-driven clinical trials, refined patient selection, and the incorporation of genomic and immune signatures to personalize therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Columbia University Irving Medical Center, New York, NY.
- Department of Medicine, Columbia University Irving Medical Center, New York, NY. Electronic address: bp2655@cumc.columbia.edu.
Zitieren
APA
Tolu, S. S., & Pro, B. (2026). SOHO State of the Art Updates and Next Questions | Peripheral T-Cell Lymphoma: Current Landscape and Emerging Questions. Clinical Lymphoma Myeloma and Leukemia, 26(6), 341-350. https://doi.org/10.1016/j.clml.2026.02.007
Vancouver
Tolu SS, Pro B. SOHO State of the Art Updates and Next Questions | Peripheral T-Cell Lymphoma: Current Landscape and Emerging Questions. Clinical Lymphoma Myeloma and Leukemia. 2026;26(6):341-350. doi:10.1016/j.clml.2026.02.007
BibTeX
@article{Tolu2026,
author = {Tolu, Seda S and Pro, Barbara},
title = {SOHO State of the Art Updates and Next Questions | Peripheral T-Cell Lymphoma: Current Landscape and Emerging Questions},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {6},
pages = {341--350},
doi = {10.1016/j.clml.2026.02.007}
}
EUVIMED